Your browser doesn't support javascript.
loading
CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice.
Sepasi, Tina; Ghadiri, Tahereh; Ebrahimi-Kalan, Abbas; Bani, Farhad; Talebi, Mehdi; Rahbarghazi, Reza; Khodakarimi, Sina; Beyrampour-Basmenj, Hanieh; Seidi, Khaled; Abbaspour-Ravasjani, Soheil; Sadeghi, Mohammad-Reza; Zarebkohan, Amir; Gao, Huile.
Afiliação
  • Sepasi T; Department of Medical Nanotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ghadiri T; Department of Neuroscience and Cognitive, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ebrahimi-Kalan A; Department of Neuroscience and Cognitive, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Bani F; Department of Medical Nanotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Talebi M; Stem Cells Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Rahbarghazi R; Stem Cells Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Applied Cell Sciences, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Khodakarimi S; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Neuroscience and Cognitive, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Beyrampour-Basmenj H; Department of Medical Biotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Seidi K; Polymer Research Laboratory, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
  • Abbaspour-Ravasjani S; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Sadeghi MR; Department of Medical Biotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Zarebkohan A; Department of Medical Nanotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: zarebkohana@tbzmed.ac.ir.
  • Gao H; Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610064, PR China. Electronic ad
Int J Pharm ; 636: 122815, 2023 Apr 05.
Article em En | MEDLINE | ID: mdl-36907279
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quitosana / Encefalomielite Autoimune Experimental / Nanopartículas Tipo de estudo: Guideline / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quitosana / Encefalomielite Autoimune Experimental / Nanopartículas Tipo de estudo: Guideline / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article